AGREEing on clinical practice guidelines for idiopathic steroid-sensitive nephrotic syndrome in children

Khalid Abdulaziz Alhasan1,2, Reem Al Khalifah3, Majed Aloufi4,5

  • 1Pediatric Nephrology Unit, Pediatrics Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Systematic Reviews
|May 11, 2021
PubMed

Insights

This study reviewed clinical practice guidelines for childhood nephrotic syndrome. The KDIGO guideline demonstrated superior methodological quality, making it most suitable for clinical practice.

Area of Science:

  • Pediatric Nephrology
  • Clinical Practice Guidelines
  • Systematic Review

Background:

  • Nephrotic syndrome is a prevalent kidney disease in children globally.
  • Idiopathic steroid-sensitive nephrotic syndrome (SSNS) requires clear clinical guidance.
  • Evaluating the quality of existing SSNS guidelines is crucial for pediatric care.

Purpose of the Study:

  • To critically appraise the quality of recent Clinical Practice Guidelines (CPGs) for pediatric SSNS.
  • To summarize and compare recommendations from selected CPGs.
  • To identify the most methodologically sound guideline for clinical application.

Main Methods:

  • Systematic review of CPGs using bibliographic and guideline databases.
  • Assessment of CPGs using the Appraisal of Guidelines for REsearch & Evaluation II (AGREE-II) instrument.
  • Comparison of guideline recommendations in a practical table.

Main Results:

  • Three CPGs were appraised: KDIGO (2012), JSPN (2014), and AAP (2009).
  • KDIGO and JSPN scored >70% overall, indicating good evidence-based quality.
  • KDIGO, JSPN, and AAP scored 84%, 74%, and 41% in rigor of development, respectively.

Conclusions:

  • The KDIGO CPG exhibited superior methodological quality compared to JSPN and AAP guidelines.
  • JSPN and AAP guidelines also provide relevant recommendations for pediatric SSNS management.
  • The KDIGO guideline is recommended for practical use in managing childhood SSNS.
Abstract

Related Concept Videos

Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
100
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
231
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
52
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
62
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
169
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
71